Icon

SOLTAMOX (nda021807)- (EQ 20MG BASE/10ML)

TAMOXIFEN CITRATE MAYNE PHARMA COMMRCL
EQ 20MG BASE/10ML
No Yes
2018-Jun-26 Expired
None None
None No
SOLTAMOX is an estrogen agonist/antagonist indicated:  For treatment of adult patients with estrogen receptor-positive metastatic breast cancer  For adjuvant treatment of adult patients with early stage estrogen receptor-positive breast cancer  To reduce risk of invasive breast cancer following breast surgery and radiation in adult women with ductal carcinoma in situ (DCIS)  To reduce the incidence of breast cancer in adult women at high risk.
0 0 0
Total Other Developers 1
Drugs with Suitability No
EQ 20MG BASE/10ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.